0001775697-22-000383.txt : 20220428 0001775697-22-000383.hdr.sgml : 20220428 20220428130128 ACCESSION NUMBER: 0001775697-22-000383 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220228 FILED AS OF DATE: 20220428 PERIOD START: 20221130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BNY Mellon Strategic Funds, Inc. CENTRAL INDEX KEY: 0000737520 IRS NUMBER: 133272460 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-03940 FILM NUMBER: 22864663 BUSINESS ADDRESS: STREET 1: C/O BNY MELLON INVESTMENT ADVISER, INC. STREET 2: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 2129226400 MAIL ADDRESS: STREET 1: C/O BNY MELLON INVESTMENT ADVISER, INC. STREET 2: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10166 FORMER COMPANY: FORMER CONFORMED NAME: Strategic Funds, Inc. DATE OF NAME CHANGE: 20060518 FORMER COMPANY: FORMER CONFORMED NAME: DREYFUS PREMIER NEW LEADERS FUND INC DATE OF NAME CHANGE: 20021213 FORMER COMPANY: FORMER CONFORMED NAME: DREYFUS NEW LEADERS FUND INC DATE OF NAME CHANGE: 19920703 0000737520 S000015657 BNY Mellon International Stock Fund C000042694 Class A DISAX C000042695 Class C DISCX C000042696 Class I DISRX C000130441 Class Y DISYX NPORT-P 1 primary_doc.xml NPORT-P false 0000737520 XXXXXXXX S000015657 C000042694 C000042695 C000042696 C000130441 BNY Mellon Strategic Funds, Inc. 811-03940 0000737520 549300KOXIZHC0IVRM71 240 Greenwich Street New York 10286 212 495 1784 BNY Mellon International Stock Fund S000015657 549300KKLHYK1M7PY666 2022-11-30 2022-02-28 N 6550851735.90 5833298.46 6545018437.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1288526.85 N SAP SE 529900D6BF99LW9R2E68 SAP SE N/A 1047700.00 NS 119024010.88 1.8185435536611 Long EC CORP DE N 1 N N N KUEHNE + NAGEL INTERNATIONAL AG 529900Q0YED3805QXQ66 KUEHNE + NAGEL INTERNATIONAL AG N/A 667600.00 NS 183005822.70 2.7961085892919 Long EC CORP CH N 1 N N N MAKITA CORP 529900CDR9E94BCM6294 MAKITA CORP N/A 2050900.00 NS 72695320.31 1.1106969522676 Long EC CORP JP N 1 N N N FANUC CORP 529900QTSW745LOKW705 FANUC CORP N/A 661200.00 NS 121669081.89 1.8589570534134 Long EC CORP JP N 1 N N N ROCHE HOLDING AG 549300U41AUUVOAAOB37 ROCHE HOLDING AG N/A 482300.00 NS 183985012.54 2.8110694308748 Long EC CORP CH N 1 N N N SHIN-ETSU CHEMICAL CO LTD 353800PX8Q64N86H5W41 SHIN-ETSU CHEMICAL CO LTD N/A 1011600.00 NS 155481859.70 2.3755755799034 Long EC CORP JP N 1 N N N TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 549300KB6NK5SBD14S87 TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 874039100 2177200.00 NS USD 232982172.00 3.5596870234505 Long EC CORP TW N 1 N N N HANG LUNG PROPERTIES LTD 529900CIVTNMXQT59E61 HANG LUNG PROPERTIES LTD N/A 40583000.00 NS 85065075.63 1.2996919174955 Long EC CORP HK N 1 N N N LVMH MOET HENNESSY LOUIS VUITTON SE IOG4E947OATN0KJYSD45 LVMH MOET HENNESSY LOUIS VUITTON SE N/A 256400.00 NS 189713661.15 2.8985962830106 Long EC CORP FR N 1 N N N ADIDAS AG 549300JSX0Z4CW0V5023 ADIDAS AG N/A 493000.00 NS 117216203.81 1.7909224386516 Long EC CORP DE N 1 N N N SGS SA 2138007JNS19JHNA2336 SGS SA N/A 42000.00 NS 120673863.26 1.8437513112216 Long EC CORP CH N 1 N N N TOTALENERGIES SE 529900S21EQ1BO4ESM68 TOTALENERGIES SE N/A 2042104.00 NS 104387838.32 1.5949204622994 Long EC CORP FR N 1 N N N NOVO NORDISK A/S 549300DAQ1CVT6CXN342 NOVO NORDISK A/S N/A 2033000.00 NS 209062158.90 3.1942180285403 Long EC CORP DK N 1 N N N SMC CORP 353800O40V08DOZ70X62 SMC CORP N/A 314100.00 NS 185921845.78 2.8406619103844 Long EC CORP JP N 1 N N N PRUDENTIAL PLC 5493001Z3ZE83NGK8Y12 PRUDENTIAL PLC N/A 8449600.00 NS 128823847.92 1.9682732623498 Long EC CORP GB N 1 N N N JARDINE MATHESON HOLDINGS LTD 2138009KENVUNWOLPK41 JARDINE MATHESON HOLDINGS LTD N/A 983100.00 NS USD 58494450.00 0.8937247550807 Long EC CORP BM N 1 N N N NOVARTIS AG 5493007HIVTX6SY6XD66 NOVARTIS AG N/A 1630100.00 NS 142800386.00 2.1818179332105 Long EC CORP CH N 1 N N N EXPERIAN PLC 635400RXXHHYT1JTSZ26 EXPERIAN PLC N/A 3750400.00 NS 147563969.73 2.2545997561424 Long EC CORP JE N 1 N N N NESTLE SA KY37LUS27QQX7BB93L28 NESTLE SA N/A 1219000.00 NS 159210358.74 2.4325425552547 Long EC CORP CH N 1 N N N AIA GROUP LTD ZP5ILWVSYE4LJGMMVD57 AIA GROUP LTD N/A 15578600.00 NS 161973901.42 2.4747661594572 Long EC CORP HK N 1 N N N AIR LIQUIDE SA 969500MMPQVHK671GT54 AIR LIQUIDE SA N/A 782600.00 NS 130482800.17 1.9936200549656 Long EC CORP FR N 1 N N N LONZA GROUP AG 549300EFW4H2TCZ71055 LONZA GROUP AG N/A 117600.00 NS 81733987.57 1.2487969033433 Long EC CORP CH N 1 N N N ASML HOLDING NV 724500Y6DUVHQD6OXN27 ASML HOLDING NV N/A 331990.00 NS 222936804.33 3.4062059024114 Long EC CORP NL N 1 N N N DAIKIN INDUSTRIES LTD 549300Y7FWSTSHMW5Y57 DAIKIN INDUSTRIES LTD N/A 795100.00 NS 146654159.96 2.2406989584793 Long EC CORP JP N 1 N N N NOVOZYMES A/S 529900T6WNZXD2R3JW38 NOVOZYMES A/S N/A 2005512.00 NS 131584324.20 2.0104500156529 Long EC CORP DK N 1 N N COLOPLAST A/S 529900NN7SOJ5QG82X67 COLOPLAST A/S N/A 684800.00 NS 103055534.45 1.5745644635694 Long EC CORP DK N 1 N N N CHR HANSEN HOLDING A/S 549300MKPW8ZF3E8MW37 CHR HANSEN HOLDING A/S N/A 1592000.00 NS 116309844.72 1.7770743632235 Long EC CORP DK N 1 N N DIAGEO PLC 213800ZVIELEA55JMJ32 DIAGEO PLC N/A 3553000.00 NS 177546518.88 2.7126970011935 Long EC CORP GB N 1 N N N INDUSTRIA DE DISENO TEXTIL SA 549300TTCXZOGZM2EY83 INDUSTRIA DE DISENO TEXTIL SA N/A 4400000.00 NS 116430600.00 1.7789193584845 Long EC CORP ES N 1 N N SMITH & NEPHEW PLC 213800ZTMDN8S67S1H61 SMITH & NEPHEW PLC N/A 6856300.00 NS 122973602.64 1.8788885595271 Long EC CORP GB N 1 N N N MERCK KGAA 529900OAREIS0MOPTW25 MERCK KGAA N/A 748400.00 NS 148989928.42 2.2763866877398 Long EC CORP DE N 1 N N N CANADIAN NATIONAL RAILWAY CO 3SU7BEP7TH9YEQOZCS77 CANADIAN NATIONAL RAILWAY CO N/A 1218400.00 NS 151148888.36 2.3093729957332 Long EC CORP CA N 1 N N N GIVAUDAN SA 213800SVRMQA1TD91D41 GIVAUDAN SA N/A 33400.00 NS 140250136.30 2.1428531888881 Long EC CORP CH N 1 N N N CSL LTD 529900ECSECK5ZDQTE14 CSL LTD N/A 686800.00 NS 129683961.94 1.9814147687981 Long EC CORP AU N 1 N N N SYSMEX CORP 5299001ZO4CKWACMZI55 SYSMEX CORP N/A 1382900.00 NS 109751486.10 1.6768705412987 Long EC CORP JP N 1 N N N MURATA MANUFACTURING CO LTD 529900QZG6DL8ZRI7140 MURATA MANUFACTURING CO LTD N/A 1900000.00 NS 128693950.33 1.9662885836015 Long EC CORP JP N 1 N N N COCHLEAR LTD 5493001OLLWY8KV5UC08 COCHLEAR LTD N/A 431100.00 NS 69791757.60 1.0663340106234 Long EC CORP AU N 1 N N N KEYENCE CORP 529900M7PQBS7A89DZ11 KEYENCE CORP N/A 427280.00 NS 199879253.69 3.0539142952847 Long EC CORP JP N 1 N N N DASSAULT SYSTEMES SE 96950065LBWY0APQIM86 DASSAULT SYSTEMES SE N/A 3026000.00 NS 147557329.72 2.2544983047857 Long EC CORP FR N 1 N N N MISUMI GROUP INC 353800SJWGE5BEK2V032 MISUMI GROUP INC N/A 1837800.00 NS 58587718.00 0.8951497778043 Long EC CORP JP N 1 N N N HOYA CORP 353800X4VR3BHEUCJB42 HOYA CORP N/A 1120900.00 NS 144835119.38 2.2129062089647 Long EC CORP JP N 1 N N N CLP HOLDINGS LTD 25490002BUTSMP94GO68 CLP HOLDINGS LTD N/A 9862500.00 NS 100396933.30 1.5339442395714 Long EC CORP HK N 1 N N L'OREAL SA 529900JI1GG6F7RKVI53 L'OREAL SA N/A 358000.00 NS 142499662.50 2.1772232402715 Long EC CORP FR N 1 N N N KONE OYJ 2138001CNF45JP5XZK38 KONE OYJ N/A 1564500.00 NS 91884766.84 1.4038885866903 Long EC CORP FI N 1 N N N ALIMENTATION COUCHE-TARD INC 549300OSW32RVX8CCZ87 ALIMENTATION COUCHE-TARD INC N/A 4259900.00 NS 167203175.54 2.5546631707488 Long EC CORP CA N 1 N N N COMPASS GROUP PLC 2138008M6MH9OZ6U2T68 COMPASS GROUP PLC N/A 6860800.00 NS 155911748.61 2.3821437647619 Long EC CORP GB N 1 N N N DREYFUS INSTITUTIONAL PREFERRE 549300RBWL04JG8SIX57 Dreyfus Institutional Preferred Government Plus Money Market Fund N/A 210969782.52 OU Other Units USD 210969782.52 3.2233642202315 Long STIV RF US N 1 2099-12-01 Variable 0.096445 N N N N N N 99VVB9HH4 N/A DREYFUS INST PREF GOVT PLUS-SL #4134 99VVB9HH4 33353853.81 OU Other Units USD 33353853.81 0.5096067204211 Long RF US N 1 N N 2022-04-22 BNY Mellon Advantage Funds, Inc. James Windels James Windels Fund Treasurer XXXX NPORT-EX 2 c10322bnymello-february20221.htm Untitled Document

STATEMENT OF INVESTMENTS
BNY Mellon International Stock Fund

February 28, 2022 (Unaudited)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 96.5%

     

Australia - 3.0%

     

Cochlear

   

431,100

 

69,791,758

 

CSL

   

686,800

 

129,683,962

 
    

199,475,720

 

Canada - 4.9%

     

Alimentation Couche-Tard

   

4,259,900

 

167,203,176

 

Canadian National Railway

   

1,218,400

 

151,148,888

 
    

318,352,064

 

Denmark - 8.6%

     

Chr. Hansen Holding

   

1,592,000

a,b 

116,309,845

 

Coloplast, Cl. B

   

684,800

 

103,055,534

 

Novo Nordisk, Cl. B

   

2,033,000

 

209,062,159

 

Novozymes, Cl. B

   

2,005,512

a 

131,584,324

 
    

560,011,862

 

Finland - 1.4%

     

Kone, Cl. B

   

1,564,500

 

 91,884,767

 

France - 10.9%

     

Air Liquide

   

782,600

 

130,482,800

 

Dassault Systemes

   

3,026,000

b 

147,557,330

 

L'Oreal

   

358,000

 

142,499,662

 

LVMH

   

256,400

 

189,713,661

 

TotalEnergies

   

2,042,104

 

104,387,838

 
    

714,641,291

 

Germany - 5.9%

     

adidas

   

493,000

b 

117,216,204

 

Merck

   

748,400

b 

148,989,928

 

SAP

   

1,047,700

 

119,024,011

 
    

385,230,143

 

Hong Kong - 6.2%

     

AIA Group

   

15,578,600

b 

161,973,901

 

CLP Holdings

   

9,862,500

a 

100,396,933

 

Hang Lung Properties

   

40,583,000

 

85,065,076

 

Jardine Matheson Holdings

   

983,100

b 

58,494,450

 
    

405,930,360

 

Ireland - 2.2%

     

Experian

   

3,750,400

 

 147,563,970

 

Japan - 20.2%

     

Daikin Industries

   

795,100

 

146,654,160

 

FANUC

   

661,200

 

121,669,082

 

Hoya

   

1,120,900

 

144,835,119

 


STATEMENT OF INVESTMENTS (Unaudited) (continued)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 96.5% (continued)

     

Japan - 20.2% (continued)

     

Keyence

   

427,280

 

199,879,254

 

Makita

   

2,050,900

 

72,695,320

 

MISUMI Group

   

1,837,800

 

58,587,718

 

Murata Manufacturing

   

1,900,000

 

128,693,950

 

Shin-Etsu Chemical

   

1,011,600

 

155,481,860

 

SMC

   

314,100

 

185,921,846

 

Sysmex

   

1,382,900

 

109,751,486

 
    

1,324,169,795

 

Netherlands - 3.4%

     

ASML Holding

   

331,990

 

 222,936,804

 

Spain - 1.8%

     

Industria de Diseno Textil

   

4,400,000

a,b 

 116,430,600

 

Switzerland - 15.5%

     

Givaudan

   

33,400

 

140,250,136

 

Kuehne + Nagel International

   

667,600

b 

183,005,823

 

Lonza Group

   

117,600

 

81,733,988

 

Nestle

   

1,219,000

 

159,210,359

 

Novartis

   

1,630,100

 

142,800,386

 

Roche Holding

   

482,300

 

183,985,012

 

SGS

   

42,000

 

120,673,863

 
    

1,011,659,567

 

Taiwan - 3.6%

     

Taiwan Semiconductor Manufacturing, ADR

   

2,177,200

 

 232,982,172

 

United Kingdom - 8.9%

     

Compass Group

   

6,860,800

 

155,911,749

 

Diageo

   

3,553,000

 

177,546,519

 

Prudential

   

8,449,600

b 

128,823,848

 

Smith & Nephew

   

6,856,300

 

122,973,603

 
    

585,255,719

 

Total Common Stocks (cost $4,029,396,993)

   

6,316,524,834

 
  

1-Day
Yield (%)

     

Investment Companies - 3.2%

     

Registered Investment Companies - 3.2%

     

Dreyfus Institutional Preferred Government Plus Money Market Fund, Institutional Shares
(cost $210,969,783)

 

0.10

 

210,969,783

c 

 210,969,783

 


        
 
        

Investment of Cash Collateral for Securities Loaned - .5%

     

Registered Investment Companies - .5%

     

Dreyfus Institutional Preferred Government Plus Money Market Fund, SL Shares
(cost $33,353,857)

 

0.10

 

33,353,857

c 

 33,353,857

 

Total Investments (cost $4,273,720,633)

 

100.2%

 

6,560,848,474

 

Liabilities, Less Cash and Receivables

 

(.2%)

 

(15,830,037)

 

Net Assets

 

100.0%

 

6,545,018,437

 

ADR—American Depository Receipt

a Security, or portion thereof, on loan. At February 28, 2022, the value of the fund’s securities on loan was $33,004,988 and the value of the collateral was $33,353,857. In addition, the value of collateral may include pending sales that are also on loan.

b Non-income producing security.

c Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company’s prospectus.


The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) is the exclusive reference of authoritative U.S. generally accepted accounting principles (“GAAP”) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the SEC under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund’s financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund’s investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

Level 1—unadjusted quoted prices in active markets for identical investments.

Level 2—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

Level 3—significant unobservable inputs (including the fund’s own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund’s investments are as follows:

Investments in equity securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. For open short positions, asked prices are used for valuation


purposes. Bid price is used when no asked price is available. Registered investment companies that are not traded on an exchange are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices. U.S. Treasury Bills are valued at the mean price between quoted bid prices and asked prices by an independent pricing service (the “Service”) approved by the Board Members (“Board”). These securities are generally categorized within Level 2 of the fair value hierarchy.

The Service’s procedures are reviewed by BNY Mellon under the general supervision of the Board.

Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant American Depository Receipts and futures. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to accurately reflect fair value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded (for example, a foreign exchange or market), but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the Board. Certain factors may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For securities where observable inputs are limited, assumptions about market activity and risk are used and such securities are generally categorized within Level 3 of the fair value hierarchy.

At February 28, 2022, accumulated net unrealized appreciation on investments was $2,287,127,841, consisting of $2,389,500,830 gross unrealized appreciation and $102,372,989 gross unrealized depreciation.

At February 28, 2022, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Statement of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.